Drugs / Hib-MenC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00352963 | Sep 2003 → Jul 2004 | diphtheria, hepatitis B virus infection, poliomyelitis, tetanus | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hib-MenC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00352963 ↗ |
| Modality | Vaccine | “Study vaccines: IH+Hib-MenC/NVC; Control: IH+Meningitec” NCT00352963 ↗ |